Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Analysis of the Outcomes From Protocolized Perioperative Care for Patients Receiving Total Hip or Knee Arthroplasty

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03071250
Recruitment Status : Completed
First Posted : March 6, 2017
Last Update Posted : July 24, 2019
Sponsor:
Information provided by (Responsible Party):
University of Arkansas

Brief Summary:

The care for patients receiving total hip and knee arthroplasty at the University of Arkansas for Medical Sciences has followed a structured care pathway since July 2015. This system of perioperative care has focused on preoperative assessment of medical co-morbidities and risks to postoperative functional recovery, anesthetic care focused on postoperative nausea and vomiting prevention and optimizing immediate postoperative functional ability, and aggressive postoperative physical therapy.

This is an observational study to look at the outcomes of this program at University of Arkansas for Medical Sciences. Areas of focus will be hospital length of stay, postoperative narcotic consumption, Visual Analog Scale scores, incidence of postoperative nausea and vomiting, and 30-day readmission rates, and health literacy rates.


Condition or disease Intervention/treatment
Knee Osteoarthritis Hip Osteoarthritis Knee Arthritis Hip Arthritis Procedure: Total knee or Hip Arthroplasty

Layout table for study information
Study Type : Observational
Actual Enrollment : 500 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: An Analysis of the Outcomes From Protocolized Perioperative Care for Patients Receiving Total Hip or Knee Arthroplasty
Actual Study Start Date : October 1, 2018
Actual Primary Completion Date : June 1, 2019
Actual Study Completion Date : July 1, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Knee Replacement


Intervention Details:
  • Procedure: Total knee or Hip Arthroplasty
    Patients who received either a total knee or hip arthroplasty will be identified


Primary Outcome Measures :
  1. Length of Stay [ Time Frame: 7/1/2015 - 7/1/2016 ]
    Postoperative hospital length of stay


Secondary Outcome Measures :
  1. narcotic consumption [ Time Frame: 7/1/2015 - 7/1/2016 ]
    30-day postoperative narcotic consumption

  2. Pain scores [ Time Frame: 7/1/2015 - 7/1/2016 ]
    postoperative VAS pain scores

  3. 30-day readmission [ Time Frame: 7/1/2015 - 7/1/2016 ]
    30-day hospital readmission following procedure

  4. infection [ Time Frame: 7/1/2015 - 7/1/2016 ]
    Surgical site infections

  5. PONV [ Time Frame: 7/1/2015 - 7/1/2016 ]
    postoperative nausea and vomiting



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Subjects must meet all of the inclusion and exclusion criteria to be enrolled in the study.

All men and women 18 years and older who underwent total hip arthroplasty or total knee arthroplasty surgery at UAMS between 7/01/2015 and 7/01/2016.

Criteria

Inclusion Criteria:

- All men and women 18 years and older who underwent total hip arthroplasty or total knee arthroplasty surgery at UAMS between 7/01/2015 and 7/01/2016.

Exclusion Criteria:

- none


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03071250


Locations
Layout table for location information
United States, Arkansas
University of Arkansas for MEdical Sciences
Little Rock, Arkansas, United States, 72205
Sponsors and Collaborators
University of Arkansas
Layout table for additonal information
Responsible Party: University of Arkansas
ClinicalTrials.gov Identifier: NCT03071250    
Other Study ID Numbers: 206501
First Posted: March 6, 2017    Key Record Dates
Last Update Posted: July 24, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Arthritis
Osteoarthritis
Osteoarthritis, Knee
Osteoarthritis, Hip
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases